这些规定旨在确保质量控制、建立不良反应报告机制和规范成分标签。
The regulations aim to ensure quality control, reporting of adverse effects and proper labelling of contents.
该药标签中的“警告”和“过量”栏目正在被修改，以反映上述潜在的不良事件。
The "warnings" and "overdosage" sections of the drug's labeling are being changed to reflect these potential adverse events.
这也表明尽管目前在目前在标签上增加了关于引起腱断裂的警告，仍有大量的腱相关不良反应持续报道。
It also demonstrates that despite the current warning of tendon rupture in the labelling, large Numbers of tendon-related adverse events continue to be reported.
标题：罗氏芬（头孢曲松钠）标签中禁忌症，注意事项，警告，不良反应，剂量和用法的修订。
Title: Rocephin (Ceftriaxone Sodium) - Contraindications, Warnings, Precautions, Adverse Reactions, Dosage and Administration Sections of Labeling Revised.
标题：罗氏芬（头孢曲松钠）标签中禁忌症，注意事项，警告，不良反应，剂量和用法的修订。
Title: Rocephin (Ceftriaxone Sodium) - Contraindications, Warnings, Precautions, Adverse Reactions, Dosage and Administration Sections of Labeling Revised.
应用推荐